Effect of eugenol on spreading depression and epileptiform discharges in rat neocortical and hippocampal tissues

Neuroscience

Volumn 140, Issue 2, 2006, Pages 743-751

  Muller M ^a   Pape, H C ^a   Speckmann, E J ^a   Gorji, A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

headache; medicinal plants; medieval pharmacotherapy; seizure; synapse

Indexed keywords

EUGENOL; MAGNESIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; EPILEPTIC DISCHARGE; HIPPOCAMPUS; NEOCORTEX; NERVE CELL PLASTICITY; NONHUMAN; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RAT; SPREADING CORTICAL DEPRESSION;

ACTION POTENTIALS; ANALGESICS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; EPILEPSY; EUGENOL; HIPPOCAMPUS; LONG-TERM POTENTIATION; MAGNESIUM DEFICIENCY; MIGRAINE DISORDERS; NEOCORTEX; NEURONS; ORGAN CULTURE TECHNIQUES; RATS; SPREADING CORTICAL DEPRESSION; SYNAPTIC TRANSMISSION;

EID: 33646515518     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.036     Document Type: Article

References (52)

1. Ashton D., Willems R., de Prins E., and Wauquier A. Field-potential assay of antiepileptic drugs in the hippocampal slice. Epilepsia 29 (1988) 321-329
2. o in the human epileptogenic neocortex maintained in vitro. Brain Res 417 (1987) 199-203
3. Bigal M.E., Lipton R.B., Cohen J., and Silberstein S.D. Epilepsy and migraine. Epilepsy Behav 4 S2 (2003) 13-24
4. Brodin P. Differential inhibition of A, B and C fibres in the rat vagus nerve by lidocaine, eugenol and formaldehyde. Arch Oral Biol 30 (1985) 477-480
5. Burstein R., and Woolf C.J. Central sensitization and headache. In: Olesen J. (Ed). The headaches (1999), Lippincott Williams & Wilkins, Philadelphia
6. Cheng S.S., Liu J.Y., Tsai K.H., Chen W.J., and Chang S.T. Chemical composition and mosquito larvicidal activity of essential oils from leaves of different Cinnamomum osmophloeum provenances. J Agr Food Chem 52 (2004) 4395-4400
7. Cohen G.L. Migraine prophylactic drugs work via ion channels. Med Hypoth 65 (2005) 114-122
8. Dallmeier Zelger K.R., Zelger J.L., and Carlini E.A. New anticonvulsants derived from 4-allyl-2-methoxyphenol (eugenol). comparison with common antiepileptics in mice. Pharmacology 27 (1983) 40-49
9. Ehrmann E.H., Messer H.H., and Adams G.G. The relationship of intracanal medicaments to postoperative pain in endodontics. Int Endod J 36 (2003) 868-875
10. Goadsby P.J. New targets in the acute treatment of headache. Curr Opin Neurol 18 (2005) 283-288
11. Gold L., Back T., Arnold G., Dreier J., Einhaupl K.M., Reuter U., and Dirnagl U. Cortical spreading depression-associated hyperemia in rats. involvement of serotonin. Brain Res 783 (1998) 188-193
12. Gorji A. Spreading depression. a review of the clinical relevance. Brain Res Brain Res Rev 38 (2001) 33-60
13. Gorji A. Pharmacological treatment of headache using traditional Persian medicine. Trends Pharmacol Sci 24 (2003) 331-334
14. Gorji A., Hohling J.M., Madeja M., Straub H., Kohling R., Tuxhorn I., Ebner A., Wolf P., Panneck H.W., Behne F., Lahl R., and Speckmann E.J. Effect of levetiracetam on epileptiform discharges in human neocortical slices. Epilepsia 43 (2002) 1480-1487
15. Gorji A., and Khaleghi Ghadiri M. History of epilepsy in medieval Iranian medicine. Neurosci Biobehav Rev 25 (2001) 455-461
16. Gorji A., and Khaleghi Ghadiri M. History of headache in medieval Persian medicine. Lancet Neurol 1 (2002) 510-515
17. Gorji A., Scheller D., Straub H., Tegtmeier F., Kohling R., Hohling J.M., Tuxhorn I., Ebner A., Wolf P., Werner Panneck H., Oppel F., and Speckmann E.J. Spreading depression in human neocortical slices. Brain Res 906 (2001) 74-83
18. Gorji A., Zahn P.K., Pogatzki E.M., and Speckmann E.J. Spinal and cortical spreading depression enhance spinal cord activity. Neurobiol Dis 15 (2004) 70-79
19. Gu Y., Ge S.Y., and Ruan D.Y. Effect of 4-aminopyridine on synaptic transmission in rat hippocampal slices. Brain Res 1006 (2004) 225-232
20. 2+] in CA1-region of rat hippocampal slices. Neurosci Lett 75 (1987) 240-245
21. Ingvast-Larsson J.C., Axen V.C., and Kiessling A.K. Effects of isoeugenol on in vitro neuromuscular blockade of rat phrenic nerve-diaphragm preparations. Am J Vet Res 64 (2003) 690-693
22. Irie Y., Itokazu N., Anjiki N., Ishige A., Watanabe K., and Keung W.M. Eugenol exhibits antidepressant-like activity in mice and induces expression of metallothionein-III in the hippocampus. Brain Res 1011 (2004) 243-246
23. Ji R.R., Kohno T., Moore K.A., and Woolf C.J. Central sensitization and LTP. do pain and memory share similar mechanisms?. Trends Neurosci 26 (2003) 696-705
24. Kozam G. The effect of eugenol on nerve transmission. Oral Surg Oral Med Oral Pathol 44 (1977) 799-805
25. Lauritzen M., Hansen A.J., Kronborg D., and Wieloch T. Cortical spreading depression is associated with arachidonic acid accumulation and preservation of energy charge. J Cereb Blood Flow Metab 10 (1990) 115-122
26. Leite J.P., Neder L., Arisi G.M., Carlotti Jr. C.G., Assirati J.A., and Moreira J.E. Plasticity, synaptic strength, and epilepsy. what can we learn from ultrastructural data?. Epilepsia 46 S5 (2005) 134-141
27. Loscher W., and Schmidt D. New horizons in the development of antiepileptic drugs. the search for new targets. Epilepsy Res 60 (2004) 77-159
28. Malenka R.C., and Bear M.F. LTP and LTD. an embarrassment of riches. Neuron 44 (2004) 5-21
29. Masago R., Matsuda T., Kikuchi Y., Miyazaki Y., Iwanaga K., Harada H., and Katsuura T. Effects of inhalation of essential oils on EEG activity and sensory evaluation. J Physiol Anthropol Appl Hum Sci 19 (2000) 35-42
30. Miettinen S., Fusco F.R., Yrjanheikki J., Keinanen R., Hirvonen T., Roivainen R., Narhi M., Hokfelt T., and Koistinaho J. Spreading depression and focal brain ischemia induce cyclooxygenase-2 in cortical neurons through N-methyl-D-aspartic acid-receptors and phospholipase A2. Proc Natl Acad Sci U S A 94 (1997) 6500-6505
31. Moskowitz M.A. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci 13 (1992) 307-311
32. Netsiri C., Bradley D.P., Takeda T., Smith M.I., Papadakis N., Hall L.D., Parsons A.A., James M.F., and Huang C.L. A delayed class of BOLD waveforms associated with spreading depression in the feline cerebral cortex can be detected and characterised using independent component analysis (ICA). Magn Reson Imaging 21 (2003) 1097-1110
33. Ohkubo T., and Shibata M. The selective capsaicin antagonist capsazepine abolishes the antinociceptive action of eugenol and guaiacol. J Dent Res 76 (1997) 848-851
34. + current modulated by arachidonic acid regulates synaptic integration and threshold for LTP induction in hippocampal pyramidal cells. Proc Natl Acad Sci U S A 99 (2002) 10144-10149
35. Read S.J., Hirst W.D., Upton N., and Parsons A.A. Cortical spreading depression produces increased cGMP levels in cortex and brain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan. Brain Res 891 (2001) 69-77
36. Read S.J., and Parsons A.A. Sumatriptan modifies cortical free radical release during cortical spreading depression. A novel antimigraine action for sumatriptan?. Brain Res 870 (2000) 44-53
37. Schmitz D., Mellor J., Frerking M., and Nicoll R.A. Presynaptic kainate receptors at hippocampal mossy fiber synapses. Proc Natl Acad Sci U S A 98 (2001) 11003-11008
38. Shaw K.N., Commins S., and O'Mara S.M. Deficits in spatial learning and synaptic plasticity induced by the rapid and competitive broad-spectrum cyclooxygenase inhibitor ibuprofen are reversed by increasing endogenous brain-derived neurotrophic factor. Eur J Neurosci 17 (2003) 2438-2446
39. Silberstein S.D. Migraine pathophysiology and its clinical implications. Cephalalgia 24 S2 (2004) 2-7
40. Sneddon I.B., and Glew R.C. Contact dermatitis due to propanidid in an anaesthetist. Practitioner 211 (1973) 321-323
41. Sourdet V., and Debanne D. The role of dendritic filtering in associative long-term synaptic plasticity. Learn Mem 6 (1999) 422-447
42. Stanton P.K., Jones R.S., Mody I., and Heinemann U. Epileptiform activity induced by lowering extracellular [Mg2+] in combined hippocampal-entorhinal cortex slices. modulation by receptors for norepinephrine and N-methyl-D-aspartate. Epilepsy Res 1 (1987) 53-62
43. Suarez L.M., Suarez F., Del Olmo N., Ruiz M., Gonzalez-Escalada J.R., and Solis J.M. Presynaptic NMDA autoreceptors facilitate axon excitability. a new molecular target for the anticonvulsant gabapentin. Eur J Neurosci 21 (2005) 197-209
44. Szabadics J., and Erdelyi L. Pre- and postsynaptic effects of eugenol and related compounds on Helix pomatia L. neurons. Acta Biol Hung 51 (2000) 265-273
45. Takagi H., Takashima M., and Liou S.Y. Effect of KB-2796, a novel calcium channel blocker, on spreading depression in rat hippocampal slices. Nippon Yakurigaku Zasshi 111 (1998) 309-316
46. Thompson D., and Eling T. Mechanism of inhibition of prostaglandin H synthase by eugenol and other phenolic peroxidase substrates. Mol Pharmacol 36 (1989) 809-817
47. Umezu T., Ito H., Nagano K., Yamakoshi M., Oouchi H., Sakaniwa M., and Morita M. Anticonflict effects of rose oil and identification of its active constituents. Life Sci 72 (2002) 91-102
48. Warner T.D., and Mitchell J.A. Cyclooxygenases. new forms, new inhibitors, and lessons from the clinic. FASEB J 18 (2004) 790-804
49. Wie M.B., Won M.H., Lee K.H., Shin J.H., Lee J.C., and Suh H.W. Eugenol protects neuronal cells from excitotoxic and oxidative injury in primary cortical cultures. Neurosci Lett 225 (1997) 93-96
50. Wiedemann M., de Lima V.M., and Hanke W. Effects of antimigraine drugs on retinal spreading depression. Naunyn Schmiedebergs Arch Pharmacol 353 (1996) 552-556
51. Williams J.H., and Bliss T.V. An in vitro study of the effect of lipoxygenase and cyclo-oxygenase inhibitors of arachidonic acid on the induction and maintenance of long-term potentiation in the hippocampus. Neurosci Lett 107 (1989) 301-306
52. Yang B.H., Piao Z.G., Kim Y.B., Lee C.H., Lee J.K., Park K., Kim J.S., and Oh S.B. Activation of vanilloid receptor 1 (VR1) by eugenol. J Dent Res 82 (2003) 781-785